fasenra - benralizumab injection, solution
(Benralizumab)Astrazeneca Pharmaceuticals Lp
Usage: Fasenra is used as add-on maintenance treatment for severe eosinophilic asthma in adults and children aged 6 and older, and for treating eosinophilic granulomatosis with polyangiitis (EGPA) in adults.